体外诊断电子商务商业模式的增长机会
市场调查报告书
商品编码
1109313

体外诊断电子商务商业模式的增长机会

In Vitro Diagnostic eCommerce Business Models Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 73 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

COVID-19 加速了医疗保健的数字化,包括体外诊断 (IVD)。技术创新还为诊断领域的新电子商务平台解决方案提供了机会,重点是全球连通性、透明度、访问、可扩展性和成本效率。

本报告检查和分析全球体外诊断中的电子商务业务模式,提供有关战略要务、增长机会、竞争格局和各种用例的信息。

内容

战略要务

增长机会分析

  • 调查目的和调查方法
  • 体外诊断电子商务行业形势
  • 市场细分
  • 增长驱动力
  • 抑制增长的因素

体外诊断电子商务商业模式从宏观到微观

  • 从宏观到微观的愿景
  • 患者、提供者和医生对技术的采用
  • 跨行业合作让行业参与者能够探索潜在的合作机会
  • 行业互联互通是 B2B 和 B2C 市场力量的倍增器

供应链参与者和使用情况

  • 优先渠道和战略重点
  • 首选通道:按诊断设备类型
  • 首选渠道:按解决方案服务类型
  • 市场吸引力和合作机会

体外诊断中的 B2B/B2B2C 电子商务 - 竞争格局、供需问题、策略和用例

  • IVD 和电子商务市场的竞争环境
  • B2B 电子商务供需渠道问题
  • 体外诊断电子商务行业参与者的策略
  • B2B 供应链市场对分销价值链投资者的好处
  • 用例 - Abbott Diagnostics
  • 用例 - Siemens Healthineers
  • 用例 - Thermo Fisher Scientific Corporation
  • 用例 - LabX
  • 用例 - KWIPPED

研发供应和使用案例

  • 研发供应链-在线平台承诺市场机会
  • 用例 - ZAGENO, Inc.
  • 用例 - Science.com
  • 用例 - Wazoku

B2C 的数字/电子药房 - 竞争格局、问题、策略和用例

  • B2C 数字/电子药店的竞争环境
  • 数字/电子药房公司的 B2C 问题
  • B2C 数字/电子药房行业参与者的战略
  • 面向 B2C 的数字/电子药房提供以客户为中心的增值服务和产品
  • 使用案例 - 亚马逊药房
  • 用例 - CVS 药房
  • 案例研究 - Walgreens Boots Alliance
  • 结论

增长机会宇宙

  • 增长机会 1 - 技术支持的电子商务供应链可提供可扩展的客户体验
  • 增长机会 2 - 研发电子商务市场为研究人员和科学家开闢了机会,优化了成本和时间
  • 增长机会 3 - 用于综合疾病管理的远程药房服务

附录

  • 电子商务与电子商务的区别
  • 商业模式的转变
  • 展品清单
  • 免责声明
简介目录
Product Code: K789-55

Disruptive Differentiation in Supply Chain Management Drives New Growth Potential

Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective equipment, consumables for molecular diagnostics, vaccines, and POCT testing for SARS-Cov2. However, serious glitches in supply and logistics due to poor procurement strategies led to manufacturing delays and a surge in diagnostics and healthcare costs. Vendors of R&D prototyping, small-batch manufacturing services, and niche testing labs recorded the largest revenue drop across the value chain. The coronavirus also accelerated healthcare digitalization, including in vitro diagnostics (IVD).

Engineering and technological innovations present opportunities to create new eCommerce platform solutions in the diagnostics segment, emphasizing global connectivity, transparency, access, scalability, and cost efficiencies. These features reduce the gaps in the IVD industry, improve access, and democratize diagnostics to empower providers, payers, and patients. Lessons learned from the pandemic in 2020 and 2021 serve as the building blocks to strengthen healthcare systems, primarily timely health service delivery, attention to the healthcare workforce, need for robust health information systems, access to diagnostics (analogous to essential medicines), efficient supply chain for procurement and supplies, and seamless communication and interconnectedness, financing, leadership, and governance. eCommerce marketplaces for healthcare and IVD provide an opportunity to buy, sell, lease, market, and procure diagnostic products and service information on any internet device, such as the computer (web-based) or mobile (mCommerce). Pharmaceuticals, biotech companies, contract research organizations, hospitals, clinics, universities, laboratories, government, and customers can use these technology platforms to access the global ecosystem. While technology infrastructure within eCommerce is evolving, essential technologies enabling healthcare transactions include EDI, bar codes, cloud, product data exchange, and electronic forms. This study assesses the eCommerce business potential across sectors, creating resilient healthcare and diagnostic market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable, cost-efficient business opportunities with new B2B products, customized outsourcing services, and technology-enabled tools for efficiency and ease of operations. The IVD market is buoyant due to the soaring demand for products, molecular diagnostics, immunoassays, and POCT in chronic diseases. The rise in consumerization, telehealth, and ePharmacy also push it toward further digitalization with advanced artificial intelligence, machine learning, and the internet of things technologies. The study also examines the competitive environment, strategies, market models, and use cases for success in the IVD eCommerce platform industry.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the In Vitro Diagnostic eCommerce Platform Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Research Objective and Methodology
  • In Vitro Diagnostic Ecommerce Industry Landscape
  • Market Segmentation
  • Growth Drivers
  • Growth Drivers (continued)
  • Growth Restraints
  • Growth Restraints (continued)

Macro to Micro In Vitro Diagnostic eCommerce Business Model

  • Macro to Micro Visioning
  • Technology Adoption Among Patients, Providers, and Physicians
  • Cross-sector Collaborations Encourage Industry Players to Explore Potential Partnership Opportunities
  • Cross-sectoral Interconnectedness Acts as a Force Multiplier for B2B and B2C Markets

Supply Chain Participants and Use

  • Preferred Channels and Strategic Priorities
  • Preferred Channels and Strategic Priorities (continued)
  • Preferred Channels and Strategic Priorities (continued)
  • Preferred Channel by Diagnostic Device Type
  • Preferred Channel by Solutions and Service Types
  • Market Attractiveness and Partnership Opportunity

IVD B2B, B2B2C eCommerce-Competitive Environment, Supply-Demand Pain Points, Strategies, and Use Cases

  • Competitive Environment-IVD and eCommerce Marketplace
  • Competitive Environment-IVD and eCommerce Marketplace (continued)
  • B2B eCommerce Supply and Demand Channel Pain Points
  • Strategies of IVD eCommerce Industry Participants
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • B2B Supply Chain Marketplace Benefits for Distribution Value Chain Stakeholders
  • Use Case-Abbott Diagnostics
  • Use Case-Siemens Healthineers
  • Use Case-Thermo Fisher Scientific Corporation
  • Use Case-LabX
  • Use Case-KWIPPED

R&D Supply and Use Cases

  • R&D Supply Chain-Online Platform Promises Market Opportunities
  • Use Case-ZAGENO, Inc.
  • Use Case-Science.com
  • Use Case-Wazoku

B2C Digital/ePharmacyUse Case-WazokuCompetitive Environment, Pain Points, Strategies, and Use Cases

  • Competitive Environment-B2C Digital/ePharmacy
  • Pain Points of B2C Digital/ePharmacy Providers and Suppliers
  • Strategies of B2C Digital/ePharmacy Industry Participants
  • Strategies of IVD B2C Digital/ePharmacy Industry Participants (continued)
  • B2C Digital/ePharmacy Offers Customer-centric Value-added Services and Products
  • Use Case-Amazon Pharmacy
  • Use Case-CVS Pharmacy
  • Case Study-Walgreens Boots Alliance
  • Conclusion

Growth Opportunity Universe

  • Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability Enhanced Customer Experience
  • Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability and Enhanced Customer Experience (continued)
  • Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists
  • Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists (continued)
  • Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management
  • Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management (continued)

Appendix

  • The Difference Between eCommerce and eBusiness
  • Business Model Shift
  • Business Model Shift (continued)
  • List of Exhibits
  • Legal Disclaimer